The percentage of patients on dialysis with a mean
iPTH > 400 pg/mL and > 600 pg/mL has risen since October 20102
De-identified patient data from large and small dialysis organizations are shared with Amgen each month per contractual agreement. These data are reported cross-sectionally and from a report known as OutcomesPlus. The OutcomesPlus database began in 2004. Data are pulled monthly. Total N varies; N for August 2013 = 233,082. Because of patient switching between dialysis organizations, some duplication in patient count may occur.2
- Despite the US KDOQI™ Commentary publication in May 2010, the percentage of patients on dialysis with iPTH > 600 pg/mL has increased.1,2
- 1. Uhlig K, Berns JS, Kestenbaum B, et al. KDOQI™ US commentary on the 2009 KDIGO® clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55:773-799.
- 2. Data on file, Amgen; [OutcomesPlus Database; August 2013].